Mumbai, India , is rapidly emerging as a key hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several companies have established substantial manufacturing facilities focusing on this essential antiviral drug . Identifying the precise top manufacturers can be difficult due to fluctuating market dynamics, but reputable names often i